CANN focuses on extraction and the creation of derivative products for recreational and medical consumers….
labelling
CannaCure’s goal is “to transform the global marijuana landscape through innovative growth strategies and strategic partnerships with manufacturers of cannabis products.”…
Sharples believes that Purefarma, Pura Vida, new contract manufacturing agreements, expansion of Canadian territories, the edibles product launch and the acquisition of Opticann expanding CANN’s U.S. presence will accelerate…
Heritage is positioning itself to radically expand its sales territory….
Sharples’ plan is to leverage Opticann’s international relationships to build “an international medical product sales footprint”….
Gross revenue was $1.4-million in the second quarter of 2020, compared with nil in the three-month period ended April 30, 2019….
“In a sector rife with terrible CEOs that have wasted company treasury and goodwill…none come close to Bierman in terms of self enrichment, entitlement, and outward facing douchery,” wrote…
Growing cannabis revenues, shrinking losses, a healthy balance sheet – and now a pathway to selling branded extraction products into the Canadian market….
New licenses, deals, products – that’s all good – but it’s not the nitty gritty stuff investors are looking for now.
By “nitty-gritty” we mean – numbers.
Four weeks ago, Heritage…
“Borrowing money and expanding hard in competition with MedMen (MMEN.C) is a two-edged sword,” explained Equity Guru’s Chris Parry, “In a strong market, you’re building far more value than…